JAMIE SLAGLE: Open Payments
NPI 1366054785 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 39 payments from 15 companies in 2025. Trend: 2023 $978 · 2024 $1,409 · 2025 $936
Food & beverage: $851Education: $85
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 15 | $383 |
| Janssen Biotech, Inc. | 1 | $85 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Incyte Corporation | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| UCB, Inc. | 2 | $44 |
| Kerecis Limited | 2 | $38 |
| LEO Pharma Inc. | 2 | $37 |
| Cipher Pharmaceuticals US LLC | 1 | $37 |
| Lilly USA, LLC | 2 | $33 |
Products named: NOVACHOR, TREMFYA, Sotyktu, OPZELURA, DUPIXENT, Bimzelx, Kerecis SurgiClose, ADBRY.
Industry payments across TN — which companies pay providers there.
